OATP1B1 polymorphisms and torsemide pharmacokinetics and pharmacodynamics

被引：0
|
作者：
Vormfelde, S. V. [1 ]
Toliat, M. R. [2 ]
Schirmer, M. [1 ]
Meineke, I. [1 ]
Nuernberg, P. [2 ]
Brockmoeller, J. [1 ]
机构：
[1] Univ Gottingen, Dept Clin Pharmacol, Gottingen, Germany
[2] Univ Cologne, Cologne Ctr Genom, Cologne, Germany
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2007年 / 101卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：384 / 384
页数：1
相关论文
共 50 条
  • [41] Construction of HEK293 cells stably expressing wild-type organic anion transporting polypeptide 1B1 (OATP1B1☆1a) and variant OATP1B1☆1b and OATP1B1☆15
    Chen, M.
    Qu, B. X.
    Chen, X. L.
    Hu, H. H.
    Jiang, H. D.
    Yu, L. S.
    Zhou, Q.
    Zeng, S.
    PHARMAZIE, 2016, 71 (06): : 337 - 339
  • [42] Assessing Trans-Inhibition of OATP1B1 and OATP1B3 by Calcineurin and/or PPIase Inhibitors and Global Identification of OATP1B1/3-Associated Proteins
    Powell, John T.
    Kayesh, Ruhul
    Ballesteros-Perez, Alexandra
    Alam, Khondoker
    Niyonshuti, Pascaline
    Soderblom, Erik J.
    Ding, Kai
    Xu, Chao
    Yue, Wei
    PHARMACEUTICS, 2024, 16 (01)
  • [43] Effect of clotrimazole on transport mediated by human OATP1B1 and OATP1B3
    Gui, Chunshan
    Thompson, Lucas
    Hagenbuch, Bruno
    HEPATOLOGY, 2006, 44 (04) : 379A - 379A
  • [44] Population Pharmacokinetic (Pop-PK) Analysis of Torsemide in Healthy Korean Males Considering CYP2C9 and OATP1B1 Genetic Polymorphisms
    Jeong, Seung-Hyun
    Jang, Ji-Hun
    Cho, Hea-Young
    Lee, Yong-Bok
    PHARMACEUTICS, 2022, 14 (04)
  • [45] OATP1B1 Polymorphism as a Determinant of Erythromycin Disposition
    Lancaster, C. S.
    Bruun, G. H.
    Peer, C. J.
    Mikkelsen, T. S.
    Corydon, T. J.
    Gibson, A. A.
    Hu, S.
    Orwick, S. J.
    Mathijssen, R. H. J.
    Figg, W. D.
    Baker, S. D.
    Sparreboom, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (05) : 642 - 650
  • [46] Impact of OATP1B1 variants on colorectal cancer
    Alpertunga, Buket
    Vefai, Mehtap
    Sari, Fatih
    Ozhan, Gul
    TOXICOLOGY LETTERS, 2012, 211 : S69 - S69
  • [47] Liver uptake of cefditoren is mediated by OATP1B1 and OATP2B1 in humans and Oatp1a1, Oatp1a4, and Oatp1b2 in rats
    Wang, Hepeng
    Sun, Pengyuan
    Wang, Changyuan
    Meng, Qiang
    Liu, Zhihao
    Huo, Xiaokui
    Sun, Huijun
    Ma, Xiaodong
    Peng, Jinyong
    Liu, Kexin
    RSC ADVANCES, 2017, 7 (48): : 30038 - 30048
  • [48] Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs
    Ieiri, Ichiro
    Higuchi, Shun
    Sugiyama, Yuichi
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (07) : 703 - 729
  • [49] Cytochrome P450-3A Phenotyping Using Midazolam Is Not Altered by OATP1B1 Polymorphisms
    Ziesenitz, V. C.
    Weiss, J.
    Haefeli, W. E.
    Mikus, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (05) : 388 - 388
  • [50] Interaction of deoxyschizandrin and schizandrin B with liver uptake transporters OATP1B1 and OATP1B3
    Lu, Yanli
    Hu, Qingqing
    Chen, Lin
    Zhang, Hong
    Huang, Shibo
    Xiong, Yuqing
    Xia, Chunhua
    XENOBIOTICA, 2019, 49 (02) : 239 - 246
12345